Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Class A 300357
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 25.53
- Day Range
- CNY 24.92–25.79
- 52-Week Range
- CNY 18.44–42.93
- Bid/Ask
- CNY 25.14 / CNY 25.15
- Market Cap
- CNY 13.17 Bil
- Volume/Avg
- 8.4 Mil / 5.6 Mil
Key Statistics
- Price/Earnings (Normalized)
- 44.10
- Price/Sales
- 14.94
- Dividend Yield (Trailing)
- 0.80%
- Dividend Yield (Forward)
- 0.80%
- Total Yield
- 0.80%
Company Profile
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd is a Chinese bio-pharmaceutical company. It is engaged in the research development, production and sales of allergic diseases diagnosis and treatment products. The product portfolio of the company covers dust mites drops, dust mites skin prick diagnosis kit, silk, and others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 1,709
- Website
- http://www.wolwobiotech.com
Comparables
Valuation
|
Metric
|
300357
|
688192
|
600713
|
|---|---|---|---|
Price/Earnings (Normalized) | 44.10 | — | 10.73 |
Price/Book Value | 5.81 | 24.75 | 0.97 |
Price/Sales | 14.94 | 98.42 | 0.12 |
Price/Cash Flow | 38.51 | — | 4.30 |
Price/Earnings
300357
688192
600713
Financial Strength
|
Metric
|
300357
|
688192
|
600713
|
|---|---|---|---|
Quick Ratio | 9.37 | 1.59 | 1.07 |
Current Ratio | 9.85 | 1.80 | 1.41 |
Interest Coverage | 243.10 | −100.52 | 3.68 |
Quick Ratio
300357
688192
600713
Profitability
|
Metric
|
300357
|
688192
|
600713
|
|---|---|---|---|
Return on Assets (Normalized) | — | −66.38% | 2.27% |
Return on Equity (Normalized) | — | −99.78% | 11.52% |
Return on Invested Capital (Normalized) | — | −78.11% | 6.36% |
Return on Assets
300357
688192
600713
Drug Manufacturers - General Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Ljnwlrsz | Lgx | $720.1 Bil | |
JNJ
| Johnson & Johnson | Zfrxjbhq | Mvn | $360.8 Bil | |
MRK
| Merck & Co Inc | Hwmmxkyd | Wgf | $329.8 Bil | |
ABBV
| AbbVie Inc | Zglcrmbq | Tnylz | $283.3 Bil | |
AZN
| AstraZeneca PLC ADR | Cnjyqtjph | Xbwf | $237.7 Bil | |
NVS
| Novartis AG ADR | Pcpjfqyw | Ypftm | $203.4 Bil | |
RHHBY
| Roche Holding AG ADR | Pxkwpbkkcn | Djhw | $197.6 Bil | |
AMGN
| Amgen Inc | Nnktjvfy | Xymy | $166.4 Bil | |
PFE
| Pfizer Inc | Xlnwhnh | Nxhr | $159.7 Bil | |
SNY
| Sanofi SA ADR | Ykjxmnd | Lfln | $125.1 Bil |